Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome

European Journal of Endocrinology

Volumn 136, Issue 4, 1997, Pages 410-415

  Şahin, Yilmaz ^a   Ayata, Demet ^a   Keleştimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; C PEPTIDE; CYTOCHROME P450 ISOENZYME; GONADORELIN AGONIST; HYDROXYPROGESTERONE; INSULIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERINSULINEMIA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030997424     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360410     Document Type: Article

References (28)

1. Barnes RB, Rosenfield RL, Burstein S & Ehrmann D. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. New England Journal of Medicine 1989 320 559-565.
2. Şahin Y & Keleştimur F. 17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clinical Endocrinology 1993 39 151-155.
3. Rosenfield RL, Barnes RB, Cara JF & Lucky AV. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertility and Sterility 1990 53 785-791.
4. Burghen GA, Givens JR & Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism 1980 50 113-116.
5. Anttila L, Koskinen P, Jaatinen T, Erkkola R, Irjala K & Ruutiainen K. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovary disease. Human Reproduction 1993 8 1179-1183.
6. Poretsky L & Piper B. Insulin resistance, hypersecretion of LH and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstetrics and Gynaecology 1994 84 613-621.
7. Hatch R, Rosenfield RL, Kim MH & Tredway D. Hirsutism: Implications, etiology, and management. American Journal of Obstetrics and Gynecology 1981 140 815-830.
8. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. Journal of Clinical Endocrinology and Metabolism 1983 57 320-326.
9. Adams J, Polson DW & Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. British Medical Journal 1986 293 355-359.
10. Ardaens Y, Robert Y, Lemaitre L, Fossati P & Dewailly D. Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertility and Sterility 1991 55 1062-1068.
11. Dunaif A, Segal KR, Futterweit W & Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 38 1165-1174.
12. Tropeano G, Lucisano A, Liberale I, Barini A, Vuolo IP, Martino G et al. Insulin, C-peptide, androgens, and β-endorphin response to oral glucose in patients with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1994 78 305-309.
13. Burghen GA, Givens JR & Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism 1980 50 113-116.
14. Dunaif A & Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. Journal of Clinical Investigation 1989 83 23-29.
15. Anttila L, Ding Y, Ruutiainen K, Erkkola R, Irjala K & Huhtaniemi I. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertility and Sterility 1991 55 1057-1061.
16. Smith S, Ravnikar VA & Barbieri RL. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertility and Sterility 1987 48 72-77.
17. Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C et al. Lack of linear relationship between hyperinsulinemia and hyperandrogenism. Clinical Endocrinology 1992 36 197-202.
18. Farah MJ, Givens JR & Kitabchi AE. Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: Positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans. Journal of Clinical Endocrinology and Metabolism 1990 70 1076-1081.
19. Nestler JE, Clore JN, Strauss III JF & Blackard WG. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance and acanthosis nigricans. Journal of Clinical Endocrinology and Metabolism 1987 64 180-184.
20. Polonsky K, Jaspan J, Emmanouel D, Holmes K & Moossa AR. Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinologica 1983 102 420-127.
21. Faber OK, Kehlet H, Nadsbad S & Binder C. Kinetics of human C-peptide in man. Diabetes 1978 21 (Suppl 1) 207-209.
22. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL et al. Defects in β-cell function in functional ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1993 76 1241-1247.
23. Mahabeer S, Jialal I, Norman RJ, Naidoo C, Reddi K & Joubert SM. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease. Hormone and Metabolic Research 1989 21 502-506.
24. Cara JF & Rosenfield RL. Insulin-like growth factor-I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988 123 733-739.
25. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF & Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. New England Journal of Medicine 1992 327 157-162.
26. Rosenfield RL, Barnes RB & Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. Journal of Clinical Endocrinology Metabolism 1994 79 1686-1692.
27. Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A & Mancuso S. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. Fertility and Sterility 1992 58 296-301.
28. Nestler JE, McClanahan MA, Clore JN & Blackard WG. Insulin inhibits adrenal 17,20-lyase activity in man. Journal of Clinical Endocrinology and Metabolism 1992 74 362-367.